Literature DB >> 14662551

Decrements in volume of anterior ventromedial temporal lobe and olfactory dysfunction in schizophrenia.

Bruce I Turetsky1, Paul J Moberg, David R Roalf, Steven E Arnold, Raquel E Gur.   

Abstract

CONTEXT: Patients with schizophrenia exhibit olfactory deficits, but it is unclear whether these represent a specific abnormality. The link between olfactory impairments and regional brain abnormalities has yet to be established.
OBJECTIVES: To determine whether patients with schizophrenia exhibit volumetric deficits in the anterior ventromedial temporal lobe, the target for neuronal inputs from the olfactory bulb, and whether these are related to olfactory performance deficits.
DESIGN: A cohort study of patients and healthy control subjects who underwent both 1-mm spoiled-gradient echo magnetic resonance imaging and behavioral tests of olfaction and memory.
SETTING: Schizophrenia Research Center at the University of Pennsylvania, Philadelphia. PARTICIPANTS: Fifty-two patients with a DSM-IV diagnosis of schizophrenia and 38 healthy control subjects. Individuals were excluded for history of head trauma, significant substance abuse, and medical conditions affecting brain function or olfactory capacity. MAIN OUTCOME MEASURES: Gray matter volumes of the left and right temporal poles and the perirhinal and entorhinal cortexes; olfactory threshold detection sensitivity and identification test scores; composite indexes of verbal and spatial memory ability.
RESULTS: Patients had reduced volumes, relative to cranial size, in left (P =.003) and right (P =.01) perirhinal and left (P =.002) and right (P =.002) entorhinal cortexes, but not in the temporal pole. Perirhinal, but not entorhinal, cortical volume decrement was associated with decreased olfactory threshold sensitivity. Neither region was associated with impaired memory performance.
CONCLUSIONS: Patients with schizophrenia have reduced cortical volumes in brain regions that receive afferents directly from the olfactory bulb. Behavioral olfactory deficits are related to structural brain abnormalities in these regions.

Entities:  

Mesh:

Year:  2003        PMID: 14662551     DOI: 10.1001/archpsyc.60.12.1193

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  37 in total

1.  An odor-specific threshold deficit implicates abnormal cAMP signaling in youths at clinical risk for psychosis.

Authors:  Vidyulata Kamath; Paul J Moberg; Monica E Calkins; Karin Borgmann-Winter; Catherine G Conroy; Raquel E Gur; Christian G Kohler; Bruce I Turetsky
Journal:  Schizophr Res       Date:  2012-04-25       Impact factor: 4.939

2.  Borders, extent, and topography of human perirhinal cortex as revealed using multiple modern neuroanatomical and pathological markers.

Authors:  Song-Lin Ding; Gary W Van Hoesen
Journal:  Hum Brain Mapp       Date:  2010-09       Impact factor: 5.038

3.  Meta-analysis of olfactory function in schizophrenia, first-degree family members, and youths at-risk for psychosis.

Authors:  Paul J Moberg; Vidyulata Kamath; Dana M Marchetto; Monica E Calkins; Richard L Doty; Chang-Gyu Hahn; Karin E Borgmann-Winter; Christian G Kohler; Raquel E Gur; Bruce I Turetsky
Journal:  Schizophr Bull       Date:  2013-05-02       Impact factor: 9.306

4.  Effects of the nicotinic α7 receptor partial agonist GTS-21 on NMDA-glutamatergic receptor related deficits in sensorimotor gating and recognition memory in rats.

Authors:  Patrick M Callahan; Alvin V Terry; Ashok Tehim
Journal:  Psychopharmacology (Berl)       Date:  2014-03-05       Impact factor: 4.530

Review 5.  The subchronic phencyclidine rat model: relevance for the assessment of novel therapeutics for cognitive impairment associated with schizophrenia.

Authors:  Sanna K Janhunen; Heta Svärd; John Talpos; Gaurav Kumar; Thomas Steckler; Niels Plath; Linda Lerdrup; Trine Ruby; Marie Haman; Roger Wyler; Theresa M Ballard
Journal:  Psychopharmacology (Berl)       Date:  2015-06-14       Impact factor: 4.530

6.  Olfactory physiological impairment in first-degree relatives of schizophrenia patients.

Authors:  Bruce I Turetsky; Christian G Kohler; Raquel E Gur; Paul J Moberg
Journal:  Schizophr Res       Date:  2008-05-05       Impact factor: 4.939

Review 7.  Recollection and familiarity in schizophrenia: a quantitative review.

Authors:  Laura A Libby; Andrew P Yonelinas; Charan Ranganath; J Daniel Ragland
Journal:  Biol Psychiatry       Date:  2012-12-14       Impact factor: 13.382

8.  Neuropathological and Reelin deficiencies in the hippocampal formation of rats exposed to MAM; differences and similarities with schizophrenia.

Authors:  Julien Matricon; Alfredo Bellon; Helge Frieling; Oussama Kebir; Gwenaëlle Le Pen; Frédéric Beuvon; Catherine Daumas-Duport; Thérèse M Jay; Marie-Odile Krebs
Journal:  PLoS One       Date:  2010-04-22       Impact factor: 3.240

9.  Depth of the olfactory sulcus: a marker of early embryonic disruption in schizophrenia?

Authors:  Bruce I Turetsky; Patrick Crutchley; Jeffrey Walker; Raquel E Gur; Paul J Moberg
Journal:  Schizophr Res       Date:  2009-09-20       Impact factor: 4.939

Review 10.  Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.

Authors:  Jared W Young; Susan B Powell; Victoria Risbrough; Hugh M Marston; Mark A Geyer
Journal:  Pharmacol Ther       Date:  2009-03-06       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.